全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2012 

Wolfram Syndrome: New Mutations, Different Phenotype

DOI: 10.1371/journal.pone.0029150

Full-Text   Cite this paper   Add to My Lib

Abstract:

Background Wolfram Syndrome (WS) is an autosomal recessive neurodegenerative disorder characterized by Diabetes Insipidus, Diabetes Mellitus, Optic Atrophy, and Deafness identified by the acronym “DIDMOAD”. The WS gene, WFS1, encodes a transmembrane protein called Wolframin, which recent evidence suggests may serve as a novel endoplasmic reticulum calcium channel in pancreatic β-cells and neurons. WS is a rare disease, with an estimated prevalence of 1/550.000 children, with a carrier frequency of 1/354. The aim of our study was to determine the genotype of WS patients in order to establish a genotype/phenotype correlation. Methodology/Principal Findings We clinically evaluated 9 young patients from 9 unrelated families (6 males, 3 females). Basic criteria for WS clinical diagnosis were coexistence of insulin-treated diabetes mellitus and optic atrophy occurring before 15 years of age. Genetic analysis for WFS1 was performed by direct sequencing. Molecular sequencing revealed 5 heterozygous compound and 3 homozygous mutations. All of them were located in exon 8, except one in exon 4. In one proband only an heterozygous mutation (A684V) was found. Two new variants c.2663 C>A and c.1381 A>C were detected. Conclusions/Significance Our study increases the spectrum of WFS1 mutations with two novel variants. The male patient carrying the compound mutation [c.1060_1062delTTC]+[c.2663 C>A] showed the most severe phenotype: diabetes mellitus, optic atrophy (visual acuity 5/10), deafness with deep auditory bilaterally 8000 Hz, diabetes insipidus associated to reduced volume of posterior pituitary and pons. He died in bed at the age of 13 years. The other patient carrying the compound mutation [c.409_424dup16]+[c.1381 A>C] showed a less severe phenotype (DM, OA).

References

[1]  Wolfram DJ (1938) Diabetes mellitus and simple optic atrophy among siblings. A report of four cases. Proc Mayo Clin 13: 715–718.
[2]  Strom TM, Hortnagel K, Hofmann S, Gekeler F, Scharfe C, et al. (1998) Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (Wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 7: 2021–2028.
[3]  Kumar S (2010) Wolfram syndrome: important implications for pediatricians and pediatric endocrinologists. Pediatr Diabetes 11: 28–37.
[4]  Barrett TG, Bundey SE, Macleod AF (1995) Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 346: 1458–1463.
[5]  Waschbisch A, Volbers B, Struffert T, Hoyer J, Schwab S, et al. (2011) Primary diagnosis of Wolfram syndrome in an adult patient-case report and description of a novel pathogenic mutation. J Neurol Sci 300: 191–193.
[6]  Inoue H, Tanizawa Y, Wasson J, Behn P, Kalidas K, et al. (1998) A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome). Nat Genet 20: 143–148.
[7]  Takeda K, Inoue H, Tanizawa Y, Matsuzaki Y, Oba J, et al. (2001) WFS1 (Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain. Hum Mol Genet 10: 477–484.
[8]  Hofmann S, Philbrook C, Gerbitz KD, Bauer MF (2003) Wolfram syndrome: structural and functional analyses of mutant and wild-type Wolframin, the WFS1 gene product. Hum Mol Genet 12: 2003–2012.
[9]  Osman AA, Saito M, Makepeace C, Permutt MA, Schlesinger P, et al. (2003) Wolframin expression induces novel ion channel activity in endoplasmic reticulum membranes and increases intracellular calcium. J Biol Chem 278: 52755–52762.
[10]  Riggs AC, Bernal-Mizrachi E, Ohsugi M, Wasson J, Fatrai S, et al. (2005) Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia 48: 2313–2321.
[11]  El-Shanti H, Lidral AC, Jarrah N, Druhan L, Ajlouni K (2000) Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q. Am J Hum Genet 66: 1229–1236.
[12]  Naserke HE, Dozio N, Ziegler AG, Bonifacio E (1998) Comparison of a novel micro-assay for insulin autoantibodies with the conventional radiobinding assay. Diabetologia 41: 681–683.
[13]  Lorini R, Orecchia G, Martinetti M, Dugoujon JM, Cuccia M (1992) Autoimmunity in vitiligo: relationship with HLA, Gm and Km polymorphisms. Autoimmunity 11: 255–260.
[14]  Maghnie M, Cosi G, Genovese E, Manca-Bitti ML, Cohen A, et al. (2003) Central diabetes insipidus in children and young adults. N Engl J Med 343: 998–1007.
[15]  Colosimo A, Guida V, Rigoli L, Di Bella C, De Luca A, et al. (2003) Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay. Hum Mutat 21: 622–629.
[16]  Gasparin MR, Crispim F, Paula SL, Freire MB, Dalbosco IS, et al. (2009) Identification of novel mutations of the WFS1 gene in Brazilian patients with Wolfram syndrome. Eur J Endocrinol 160: 309–316.
[17]  Hardy C, Khanim F, Torres R, Scott-Brown M, Seller A, et al. (1999) Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet 65: 1279–1290.
[18]  Khanim F, Kirk J, Latif F, Barrett TG (2001) WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat 17: 357–367.
[19]  Kadayifci A, Kepekci Y, Coskun Y, Huang Y (2001) Wolfram syndrome in a family with variable expression. Acta Medica 44: 115–118.
[20]  Giuliano F, Bannwarth S, Monnot S, Cano A, Chabrol B, et al. (2005) Wolfram syndrome in French population: characterization of novel mutations and polymorphisms in the WFS1 gene. Hum Mutat 25: 99–100.
[21]  Zalloua PA, Azar ST, Delépine M, Makhoul NJ, Blanc H, et al. (2008) WFS1 mutations are frequent monogenic causes of juvenile-onset diabetes mellitus in Lebanon. Hum Mol Genet 17: 4012–4021.
[22]  Rigoli L, Lombardo F, Di Bella C (2011) Wolfram syndrome and WFS1 gene. Clin Genet 79: 103–117.
[23]  Tessa A, Carbone I, Matteoli MC, Bruno C, Patrono C, et al. (2001) Identification of novel WFS1 mutations in Italian children with Wolfram syndrome. Hum Mutat 17: 348–349.
[24]  Gómez-Zaera M, Strom TM, Rodríguez B, Estivill X, Meitinger T, et al. (2001) Presence of a major WFS1 mutation in Spanish Wolfram syndrome pedigrees. Mol Genet Metab 72: 72–81.
[25]  d'Annunzio G, Minuto N, D'Amato E, De Toni T, Lombardo F, et al. (2008) Wolfram Syndrome (Diabetes Insipidus, Diabetes, Optic Atrophy, and Deafness). Diabetes Care 31: 1743–1745.
[26]  Domènech E, Gómez-Zaera M, Nunes V (2002) WFS1 mutations in Spanish patients with diabetes mellitus and deafness. Eur J Hum Genet 10: 421–426.
[27]  Fawcett KA, Wheeler E, Morris AP, Ricketts SL, Hallmans G, et al. (2010) Detailed Investigation of the Role of Common and Low-Frequency WFS1 Variants in Type 2 Diabetes Risk. Diabetes 59: 741–746.
[28]  Sequeira A, Kim C, Seguin M, Lesage A, Chawky N, et al. (2003) Wolfram Syndrome and Suicide: Evidence for a Role of WFS1 in Suicidal and Impulsive Behavior. Am J Med Genet B Neuropsychiatr Genet 119: 108–113.
[29]  Awata T, Inoue K, Kurihara S, Ohkubo T, Inoue I, et al. (2000) Missense Variations of the Gene Responsible for Wolfram Syndrome (WFS1/wolframin) in Japanese: Possible Contribution of the Arg456His Mutation to Type 1 Diabetes as a Nonautoimmune Genetic Basis. Biochem Biophys Res Commun 268: 612–616.
[30]  Smith CaseyJA (2004) Phenotype-Genotype Correlations in a Series of Wolfram Syndrome Families. Diabetes Care 27: 2003–2009.
[31]  Kinsley BT, Dumont RH, Swift M, Swift RG (1995) Morbidity and mortality in the Wolfram syndrome. Diabetes Care 187: 1566–1570.
[32]  Simsek E, Simsek T, Tekgul S, Hosal S, Seyrantepe V, et al. (2003) Wolfram (DIDMOAD) symdrome: a multidisciplinary clinical study in nine Turkish patients and review of literature. Acta Paediatr 92: 55–61.
[33]  Medlej R, Wasson J, Baz P, Azar S, Salti I, et al. (2004) Diabetes mellitus and optic atrophy: a study of Wolfram syndrome in the Lebanese population. J Clin Endocrinol Metab 89: 1656–1661.
[34]  Yamamoto H, Hofmann S, Hamasaki DI, Yamamoto H, Kreczmanski P, et al. (2006) Wolfram Syndrome 1 (WFS1) protein expression in retinal ganglion cells and optic nerve glia of the cynomolgus monkey. Exp Eye Res 83: 1303–1306.
[35]  Megighian D, Savastano M (2004) Wolfram syndrome. Int J Ped Otorhinolaryngol 68: 243–247.
[36]  Genis D, Davalos A, Molins A, Ferrer I (1997) Wolfram syndrome: a neuropathological study. Acta Neuropathol 93: 426–429.
[37]  Tekgul S, Oge O, Simsek E, Yordam N, Kendi S (1999) Urological manifestations of the Wolfram Syndrome: observations in 14 patients. J Urol 161: 616–617.
[38]  Piccoli GB, Mezza E, Jeantet A, Segoloni JP (2003) An uncommon genetic syndrome with acute renal failure in a 30-year-old diabetic patient. Nephrol Dial Transplant 18: 206–208.
[39]  Chaussenot A, Bannwarth S, Rouzier C, Vialettes B, Mkadem SA, et al. (2011) Neurologic features and genotype-phenotype correlation in wolfram syndrome. Ann Neurol 69: 501–508.
[40]  Philbrook C, Fritz E, Weiher H (2005) Expressional and functional studies of Wolframin, the gene function deficient in Wolfram Syndrome, in mice and patient cells. Exper Gerontol 40: 671–678.
[41]  Fonseca SG, Ishigaki S, Oslowski CM, Lu S, Lipson KL, et al. (2010) Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest 120: 744–755.
[42]  Cryns K, Sivakumaran TA, Van den Ouweland JM, Pennings RJ, Cremers CW, et al. (2003) Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum Mut 22: 275–287.
[43]  Tranebjaerg L, Barrett T, Rendtorff ND (2009) WFS1-Related Disorders. Gene Reviews 24:
[44]  Domenech E, Kruyer H, Gomez C, Calvo MT, Nunes V (2004) First prenatal diagnosis for wolfram syndrome by molecular analysis of the WS1 gene. Prenat Diagn 24: 787–789.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133